FindTrial
Sign In

Liver Stiffness in newly diagnosed patient with diabetics.

To see the presence of complication including hepatic fibrosis in newly diagnosed diabetics.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/054198
Enrollment
100
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with type 2 diabetes within a time period of 6 months

Exclusion criteria

Exclusion criteria: 1.Type-1 diabetics 2.Patients with secondary diabetes

Design outcomes

Primary

MeasureTime frame
To study the presence of complications including hepatic fibrosis in newly diagnosed diabetic patients.Timepoint: 12 MONTHS—

Secondary

MeasureTime frame
To correlate LTL with complications of Diabetes Mellitus.Timepoint: 12 MONTHS—

Countries

India

Contacts

Public ContactDr ANOOP MISRA

Fortis CDOC Hospital

anoopmisra@gmail.com01149101222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026